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ABSTRACT
Purpose: Genomic instability plays a major role in the
genesis and progression of tumors, and in the evolution of
tumor heterogeneity. To determine the role of genomic in-
stability in the genesis and progression of oral cancer, we
assessed the extent of genomic alterations in oral squamous
cell carcinomas (OSCCs).
Experimental Design: We used the recently developed
inter-(simple sequence repeat) PCR technique to quantitate
genomic instability using matched tumor and normal OSCC
samples (n  25). The inter-repeat region bands of similar
molecular size observed to be altered in more than one case
were sequenced and analyzed to identify probable OSSC-
associated specific genetic lesions.
Results: Of the four base-anchored, dinucleotide
repeat-based primers used for the study, the most informa-
tive profile in OSCCs was generated by the (CA)8RG
primer. Measurement of genomic instability index using the
(CA)8RG primer revealed a high incidence of genomic in-
stability in OSCCs. No significant correlation between the
extent of alterations and stage or location of the tumor was
observed. Sequencing analysis of the altered bands revealed
gains/losses in several chromosomal regions. Of the matched
tumor and corresponding normal tissue DNA studied, hith-
erto unreported losses were seen in 11p15 and 17q25 chro-
mosomal regions. Sequencing of some of the tumor-specific
altered regions indicated that they code for regions of UDP-
GalNAc and hRAD 17 genes, which were lost (deleted) in
oral cancer.
Conclusions: Our results indicate that the extent of
genomic instability in OSCC is not correlated to the tumor
stage or location. For the first time, we have shown that
chromosomal alterations detected by inter-(simple sequence
repeat) PCR could be correlated to genes associated with
cancer development.
INTRODUCTION
OSCC3 is one of the most prevalent forms of cancer in the
regions of world where tobacco chewing in combination with
alcohol consumption is high. Many molecular aberrations occur
in the genome of OSCCs such as mutations in tumor suppressor
genes p53, p16, and fhit, and deletion in p14 ARF; and in
addition a high rate of mutations in Ha-ras oncogene is also
reported. Most of these mutations were characteristic of N-
nitrosamine carcinogen damage in the DNA of OSCC patients
(1–4).
Progression of tumors has been attributed to the cumulative
accumulation of multiple alterations throughout the genome,
which is manifested by genomic instability. A mutator pheno-
type has been proposed, which destabilizes the genome, and
drives rapid progression of the tumor and continuous evolution
of microheterogeneities within the tumor (5).
Measurement of genomic instability has been made using
techniques like flow cytometry, fluorescent in situ hybridiza-
tion, CGH, and allelotyping, which, although informative, are
cumbersome to perform and, hence, impractical in the assess-
ment of clinical cases (6).
In this study, we have attempted to assess genomic insta-
bility and possibly detect tumor-specific genomic alterations in
OSCCs. We have used a rapid technique developed recently,
ISSR-PCR, for measurement of genomic instability (6–12).
Here, PCR primers homologous to dinucleotide repeats, an-
chored at the 3 end by two nonrepetitive nucleotides were used
to evaluate genomic instability. This was done by observing the
appearance (gains) or disappearance (losses) of amplified DNA
bands from tumors and matched normal tissues. ISSR-PCR is
well suited to detect common genetic events observed in spo-
radic cancers like aneuploidy, wherein entire chromosomes are
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gained or lost, as well as intrachromosomal instabilities charac-
terized by insertions, deletions, amplifications, and transloca-
tions. Furthermore, this technique is sensitive enough to detect
small alterations not detectable by CGH or flow cytometry (6).
MATERIALS AND METHODS
Tumor Samples and Isolation of DNA. Consecutive
biopsy or resection samples were collected along with normal
tissue from adjacent region in PBS, and transported on ice and
DNA isolated immediately as described (6). Briefly, 100 mg of
tissue was cleared of debris, cut into small pieces of 2–3 mm,
and digested overnight with 1 g/ml proteinase K (Sigma) in
proteinase K buffer (10 mM Tris-Cl, 5 mM EDTA, and 0.5%
SDS) at 60°C. The samples were treated with 0.5 g/ml RNase
A (Sigma) for 30 min, and extracted twice with phenol and
finally with chloroform:isoamyl alcohol. DNA was precipitated
with 95% ethanol containing 0.1 M sodium acetate. The DNA
was vacuum dried, reconstituted in Milli-Q H2O, and quanti-
tated spectrophotometrically.
ISSR-PCR. Fifty ng of the DNA sample was amplified
in a 10 l reaction containing 1 PCR buffer, 200 M de-
oxynucleoside triphosphates, 1.5 mM MgCl2, 2.5 M of one of
the base-anchored dinucleotide repeat primers (Microsynth
GmBH, Balgach, Switzerland), 0.5 units of TaqDNA polymer-
ase (Perkin-Elmer), and 5 Ci of [-P32]dCTP.
The cycling conditions were 3 min initial denaturation at
94°C, 30 cycles of 30 s at 94°C, 45 s at 50°C, and 2 min at 72°C
followed by final extension for 7 min at 72°C on a Perkin-Elmer
GeneAmp 2400 thermocycler.
The PCR product (2.5 l) was mixed with 0.5 l 6
loading buffer (30% glycerol, 1.25 mM EDTA, 0.025% xylene
cyanol, and 0.025% bromphenol blue). The products of tumor
and the corresponding normal DNA samples were loaded onto
adjacent lanes on a 0.4-mm thick 8% nondenaturing polyacryl-
amide gel with 5% glycerol, and run for 30 min at 80 W and
subsequently for 7 h at 50 W and 25°C. The gel was transferred
to a Whatman 3M paper, dried, and autoradiographed with 8 h
exposure at 70°C on a Konica-AX X-ray film. The experiments
were performed at least five times for each sample to match
intensity by adjusting the concentration of template, and to
check the reproducibility of the alterations as detected by the
gains and losses of specific bands.
Reamplification and Cloning of PCR Products. Bands
of similar mobility showing alterations in more than one tumor
sample were excised from the polyacrylamide gel, and DNA
was extracted by dissolving in 50 l of Milli-Q H2O. Five l of
the DNA was reamplified using the same conditions as above in
a 50-l reaction. The products were electrophoresed on 2%
agarose gel and purified using DE-81 membrane. Forty ng of the
above DNA was used in a 10-l ligation reaction constituting 50
ng of pGEM-T vector (Promega) according to the manufactur-
er’s instructions. Five l of the reamplified products were
electrophoresed on a 12% polyacrylamide gel, and the molec-
ular size of each fragment was determined using an Alpha
imager-ImageQuant system.
Sequencing of Clones. pGEM-T vector containing the
appropriate insert was purified, 400–500 ng of the plasmid was
used in a Big Dye (Applied Biosystems) cycle sequencing
reaction using 3.2 pmol T7 primer according to the manufac-
turer’s instructions, and capillary sequencing was performed on
an ABI prism 310 Genetic Analyzer.
Confirmation of LOH in 11p15 Region. Primers de-
signed within the altered region of 11p15 (forward, 5 CCG
AGG AGT AAG AGC AGT AAG G 3 and reverse, 5 AAC
ACA CAC ACA AGC ACC AC) and a sequence tagged site
marker in this region WI-16945 (forward, 5 TGT TGA TGG
CTT CAA ATA CTT CA 3 and reverse, 5 CAG ATG TTA
ATA CAC ACA GAC CTC G 3) were used in a 10-l multi-
plex PCR reaction containing 1 PCR buffer, 200 M de-
oxynucleoside triphosphates, 1.5 mM MgCl2, 0.2 M each
primer, and 0.5 units of TaqDNA polymerase (Perkin-Elmer)
using 50 ng of DNA as a template.
The cycling conditions were 3 min initial denaturation at
94°C, 30 cycles of 30 s at 94°C, 55°C, and 72°C, followed by
final extension for 7 min at 72°C on a Perkin-Elmer GeneAmp
2400 thermocycler.
Fig. 1 Autoradiogram of ISSR-PCR products. The PCR was done
using (CA)8RG primers, and the products were electrophoresed in 8%
polyacrylamide gels. T, tumor DNA; N, corresponding normal DNA.
Genomic instability (%) is shown below each pair of tumor and normal
samples. Genomic instability was calculated by dividing the total num-
ber of bands generated in the normal sample by the number of altered
bands.
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RESULTS
Basik et al. (6) first used ISSR-PCR to quantitate genomic
instability in sporadic colorectal cancer. Using primer based on
repetitive DNA sequences, anchored at the 3 end with unique
sequences to prevent slippage, this technique produces amplifi-
cation of those DNA sequences, typically 2 kb in size, which
are present between relatively close, inverted primer-binding
repeat sequences (6). When CA repeat based primers were used,
approximately 35–40 PCR products were generated (Fig. 1),
whereas using CT repeat-based primers, approximately 20–25
products were generated. A preliminary comparison of bands
generated by amplification of tumor and the corresponding
normal samples revealed that the profile generated by CA dinu-
cleotide-based primer showed a greater number of bands than
that of CT-based primers in accordance with the fact that CA
repeats are more widely distributed in the genome (7  106
copies) than CT (3  106 copies) dinucleotide repeats.
Tumor-specific alterations were detected as gains, losses,
and intensity changes in electrophoretic bands. It must be noted
that these alterations are not limited to insertions or deletions
between or in the primer binding sites; larger scale processes
such as deletions of portions of chromosomes or of entire
chromosomes can also eliminate the corresponding bands. Both
gains and losses were seen in the OSCC cases with a slight
preponderance of gains than losses when (CA)8RG primer was
used (Fig. 2a). No significant correlation was seen between the
extent of genomic alterations and the stage of the tumor, age of
the patient, or location of the tumor (Table 1).
We determined genomic instability according to Basik et
al. (6) by dividing the number of altered bands in the tumor by
the total number of bands in the corresponding normal tissue
sample (Fig. 2b). The median genomic instability index was
determined to be 8%.
Selected altered fragments (Fig. 3) were cloned and se-
quenced, and the sequence data obtained (GenBank accession
no. AF539907-AF539917) were subjected to sequence align-
ment by using the Basic Local Alignment Search Tool sequence
comparison tools of the National Center for Biotechnology
Information public database. Human genomic blast was initially
performed to identify the chromosomal region that matched the
sequence followed by the standard nucleotide-nucleotide
BLAST to determine the identity of the sequence using known
human gene sequences in the database (Table 2).
Loss of the chromosomal region 11p15 was observed in
five altered bands, two of them from the same sample (T3) in
different ISSR-PCR experiments. The chromosomal region
17q25 was found to be lost in three altered bands from different
samples. In the case of 11p15 the loss has been found to occur
within the gene coding for polypeptide-N acetygalactosaminyl
transferase 9 (UDP-GalNAc). The fragment from the altered
region in 3p14 was completely homologous to human RF-C
activator1 homologue (RAD 17), a human and mouse homo-
logue of Schizosaccharomyces pombe rad17, which is a cell
cycle checkpoint control gene. This is the first instance where
ISSR-PCR has detected regions within genes directly involved
in cell cycle regulation and cancer.
A multiplex PCR analysis using primers within the 11p15
altered region and an STS marker (WI 16945) in the 11p15
region was devised, and an amplicon of the human protein
phosphatase gene was used as a template control. Alterations
were detected as absence of the amplicons in 15% (6 of 40) of
the cases. One of the cases (T8) from the original ISSR-PCR
11p15 loss region showed no amplification in the multiplex
PCR reaction, whereas the other three (T3, T14, and T15) were
amplified indicating a prevalence of allelic imbalance rather
than LOH of this region in these cases (data not shown).
DISCUSSION
We have used the ISSR-PCR developed recently to inves-
tigate genomic alterations in OSCCs. The banding profile gen-
erated by ISSR-PCR was found to be reproducible and reliable.
Our observations prove that genomic instability is prevalent to a
large extent in OSCC (median  8%) and is important if not
essential in the progression of this tumor type.
Two major types of genetic instabilities have been de-
Fig. 2 a, evaluation of losses and gains in DNA bands generated by
(CA)8RG primer. The chart shows gains and losses in the 25 samples
studied with a slight preponderance of gains over losses. When gain/loss
in not present in a sample, 0 value of gain or loss generates an apparent
spacing on the X axis. b, assessment of genomic instability. Genomic
instability calculated by dividing the total number of bands generated in
the normal sample by total number of alterations in the 25 samples
studied is depicted in the histogram. When no alterations are seen, the
0 value genetic instability generates an apparent spacing in the X axis.
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scribed (13, 14), MIN, which arises because of a defective
mismatch repair system and is characterized by widespread
alterations in the microsatellite repeat regions (15), and CIN,
arising because of mutations that affect the partitioning of
chromosomes during mitosis characterized by large alterations
involving thousands of nucleotide units in DNA (16).
It is known that occurrence of MIN phenotype is relatively
low in OSCC and is evident by the fact that many LOH events
rather than alterations in repeat regions (MIN) are observed by
allelotyping of OSCC DNA with microsatellite markers (17–
25). Reports of MIN from the Asian region show various de-
grees of incidence from nil (0%) to low (4–17%) to moderate
(27–50%), whereas reports from developed regions of the world
have consistently shown low incidence (0–7%); but in all of the
studies reported LOH events occur more predominantly than
MIN (17–25).
Studies done in our laboratory using four microsatellite
markers in the chromosome region 10q22–26 using the same
tumor samples with matched normal samples used for ISSR-
PCR experiments also show that the occurrence of MIN of
repeat sequences in OSCC is comparatively rarer than LOH
events.4
The MIN phenotype is related to defects in the mismatch
repair system. Loss of expression of the mismatch repair gene,
hMLH1, predominantly by hypermethylation of the promoter
region is associated with MIN. This is seen in many human
cancer types including colorectal, pancreatic, and endometrial
cancers (26–31). Studies done in our laboratory on incidence of
hMLH1 methylation have shown this to be a rare event occur-
ring in only 8% of the 99 samples studied (32).
Our ISSR-PCR data show that the other form of genomic
instability, CIN phenotype (11), occurs to a greater extent in
OSCC regardless of the tumor stage and its location, and is
probably an early event in the progression of the disease. It has
been reported that occurrence of MSI is independent of LOH
events and of the alterations in ISSR-PCR profile. However,
there is indeed a correlation between LOH events and degree of
alterations in ISSR-PCR profile (12). In other words, the alter-
ations detected by ISSR-PCR reflect the LOH events rather than
MSI in the genome.
Recent studies have correlated the type of genomic insta-
bility (CIN/MIN) developing in a particular cancer to specific
classes of carcinogens. It has been shown that alkylating car-
Fig. 3 Autoradiogram showing losses and gains in tumors. Regions of
autoradiograms showing losses in three and gains in two tumors are
depicted. The bands showing reproducible alterations in several samples
were excised; the DNA was eluted, cloned, and sequenced to determine
the chromosomal region altered.
Table 1 TNMa stage and genomic instability index of the tumor samples used in the study
Sl. no.
Sample
no. Age Sex Site
TNM
staging
Genomic
instability (%)
1 T1/N1b 60 M Cheek lt.c T4N2M0 2.8
2 T2/N2 48 M Alveolus rt. T4N1M0 0
3 T3/N3 62 M Angle of mouth rt. T4N1M0 29.0
4 T4/N4 61 M Cheek rt. T4N0M0 16.6
5 T5/N5 60 F Lip T3N2M0 0
6 T6/N6 21 M Tongue rt. T4N2M0 20.0
7 T7/N7 60 M Cheek rt. T4N1M0 13.3
8 T8/N8 45 F Alveolus rt. T4N2M0 14.2
9 T9/N9 50 M Alveolus rt. Tx 6.0
10 T10/N10 50 M Cheek rt. T4N2M0 4.1
11 T11/N11 52 M Cheek rt. T4N1M0 8.0
12 T12/N12 50 F Cheek lt. T4N2M0 7.6
13 T13/N13 55 F Palate T4N2M0 0
14 T14/N14 40 F Tongue T4N1M0 11.0
15 T15/N15 36 F Cheek rt. T2N1M0 24.1
16 T16/N16 50 M Lip T2N1M0 0
17 T17/N17 46 F Alveolus rt. T4N1M0 29.6
18 T18/N18 60 M Angle of mouth rt. T4N2M0 9.0
19 T19/N19 67 M Cheek rt. T2N0M0 10.3
20 T20/N20 40 F Cheek rt. T4N3M0 10.7
21 T21/N21 70 M Alveolus lt. T2N0M0 3.5
22 T22/N22 45 F Cheek rt. T4N1M0 0
23 T23/N23 40 F Cheek rt. T4N1M0 9.0
24 T24/N24 55 M Tongue T4N2M0 0
25 T25/N25 70 M Cheek lt. T3N2M0 0
a TNM, Tumor-Node-Metastasis.
b T, tumor; N, normal.
c Lt., left; Rt., right.
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cinogens specifically give rise to tumors with the MIN pheno-
type, whereas bulky adduct-forming carcinogens lead to the CIN
phenotype (33).
The nature of genomic instability now detected by the
ISSR-PCR in OSCC, i.e., CIN, is indicative of the fact that DNA
adduct-forming carcinogens like benzo(a)pyrenes found in
cured smokeless tobacco might play a major role in causing
genomic instability rather than alkylating agents like N-nitro-
samines, which lead to accumulation of mutations specific to G
residues and are frequently associated with the MIN phenotype
(34). Earlier observations from our laboratory indicated a com-
paratively low incidence of mutations in the tumor suppressor
genes (3) that involve G residues (a preferential target of alky-
lating carcinogens). These findings support our hypothesis of
the possibility of a major role of benzo(a)pyrenes apart from
N-nitrosamines, thus far held responsible for the genesis of
OSCCs.
Apart from measurement of genomic instability, the ISSR-
PCR profile could also identify tumor-specific alterations in a
given cancer type (10). We were biased in our selection of
altered bands for cloning and subsequent sequencing. We
looked for bands of similar mobility that were altered in more
than one case with the aim to detect tumor-specific alterations
that could lead to development of a potential marker region
involved in OSCC. That genomic instability leads to loss of
function of genes directly involved in the cell cycle regulation,
and development of cancer is indicated by our results. Losses
were observed in UDP-GalNAc, the expression of which was
correlated directly to prognosis in colorectal cancer patients
(35). One of the sample studied showed loss of the S. pombe rad
17 gene homologue in humans. The yeast Rad 17 is involved in
DNA repair/cell cycle checkpoint; the human homologue has
the same functions and is a candidate tumor suppressor gene,
and mutations in it can lead to cancers (36).
The reliability of the ISSR-PCR in detecting tumor-specific
alterations has not been clearly demonstrated as yet. Sequencing
results showing alterations in tumor-associated genes have not
been reported, limiting the use of ISSR-PCR as a tool to quan-
tify the extent of genomic instability only. Our results for the
first time show the ability of ISSR-PCR to pick tumor-specific
alterations showing homology to the coding regions of genes
involved in the regulation of cell cycle and cancer development.
This proves that ISSR-PCR is similar to CGH or perhaps an
even more powerful technique, capable of detecting tumor-
specific alterations in the genome, which might not just be
random events caused by the CIN phenotype, but tumor- and
region-specific targeted events evident by the fact that the same
event has occurred in more than one tumor case. These alter-
ations generated by the ISSR-PCR on further study have the
potential to be developed into tumor-specific markers, and al-
though no specific mutation could be absolutely diagnostic of a
specific malignancy, the presence of an increased number of
mutations indicated by the measurement of genomic instability
index may indicate that cells were already on the path of
neoplastic growth.
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